)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Perspective Therapeutics
Perspective Therapeutics (CATX) investor relations material
Perspective Therapeutics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary16 Mar, 2026
Executive summary
Lead program VMT-a-NET in neuroendocrine tumors shows favorable tolerability and durable disease control, with deepening tumor responses over longer follow-up, as reported at ASCO-GI 2026.
All three clinical programs (VMT-a-NET, VMT01, PSV359) are advancing, with updates expected at medical conferences throughout 2026.
Cash and investments of $145M at year-end 2025, plus $164M from a February 2026 equity offering, are expected to fund operations into late 2027.
Financial highlights
Cash, cash equivalents, and short-term investments were $145M as of December 31, 2025, down from $227M at year-end 2024.
Net loss for 2025 was $103.1M ($1.40 per share), compared to $79.3M ($1.23 per share) in 2024.
Research and development expenses rose 102% to $84.2M, driven by increased clinical activity and personnel costs.
General and administrative expenses increased 14% to $30.2M.
Grant revenue was $0.9M for 2025, down from $1.5M in 2024.
Outlook and guidance
Data readouts from all clinical programs are expected throughout 2026, with regulatory engagement planned.
Cash runway is projected to support planned milestones and operations into late 2027.
VMT-a-NET patient selection strategy details
What criteria led to preclinical asset deprioritization?
Drivers of 102% R&D expense increase in 2025?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Perspective Therapeutics
- Lead-based radiopharmaceuticals advance with strong clinical progress and robust infrastructure.CATX
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Strong clinical data, innovative technology, and pipeline expansion drive growth prospects.CATX2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Strong clinical results, scalable manufacturing, and robust pipeline drive growth prospects.CATX44th Annual J.P. Morgan Healthcare Conference14 Jan 2026
- Multiple radiopharma programs advance with key data and trial milestones expected in the next year.CATXUBS Global Healthcare Conference14 Jan 2026
- Lead-212 radiopharma pipeline advances with strong early data, networked supply, and funding to 2026.CATXStifel 2024 Healthcare Conference13 Jan 2026
- Strong early efficacy and safety in radioligand pipeline, with key data and trials ahead.CATXPiper Sandler 36th Annual Healthcare Conference12 Jan 2026
- Promising clinical data and expanding pipeline highlight advances in lead-based radiotherapeutics.CATX7th Annual Evercore ISI HealthCONx Healthcare Conference11 Jan 2026
- Clinical-stage radiopharmaceuticals show strong early results and expansion, backed by solid funding.CATX43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026
- VMT-α-NET shows strong safety and efficacy, supporting dose escalation and expansion plans.CATXStatus Update9 Jan 2026
Next Perspective Therapeutics earnings date
Q1 202611 May, 2026
Perspective Therapeutics
Next Perspective Therapeutics earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage